Trial NCT03239860

View at ClinicalTrials.gov 
Org. Study IDs: GNC-004

Last trial update was posted on 2020-10-20

MeSH Interventions

Antibodies Antibodies, Monoclonal

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions


Stopping Reasons

Based on R&D strategic reasons, our co-development Partner financing the study disengaged from the development of GNbAC1.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID